Usda Organic

hqdefault12

Gene signatures predict doxorubicin response in canine osteosarcoma

There are two chemotherapies commonly used to treat bone cancer in dogs: doxorubicin and carboplatin. Some dogs respond better to one drug than to the other. But until now, the choice has been left largely to chance. New work by University of Colorado Cancer Center members at Colorado State University Flint Animal Cancer Center presented […]

Continue Reading